Back

Description of a clinical turning point after barostim therapy: is permanent atrial fibrillation always permanent?

28 May 2018 (16:10 - 16:13)
Organised by:
Congress Presentation Part of: Clinical Case Corner 5 - New treatments and interventions on the horizon Devices for Autonomic Modulation HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Ludovico Lazzari

Hospital Santa Maria, Terni (Italy)

12 More presentations in this session

Presentation thumbnail
Lung impedance as a sensitive non-invasive tool for home monitoring of lung water in the vulnerable phase
Doctor E. Grigoniene (Vilnius, LT)
Abstract Slides
Presentation thumbnail
Frailty syndrome: the same age does not mean the same health status
Ms M. Lisiak (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Progressive heart failure in patient with ccTGA after double switch operation performed in early adulthood.
Doctor M. Hegarova (Prague, CZ)
Abstract Slides
Presentation thumbnail
The role of arteriovenous fistula flow on heart failure in a dialysis patient
Doctor J. Malik (Prague, CZ)
Abstract Slides
Presentation thumbnail
MitraClip in a refractory heart failure patient: last but not the least

Access the full session

Session thumbnail
Clinical Case Corner 5 - New treatments and interventions on the horizon

The Event

Event poster

Heart Failure 2018

28 May 2018 16:10 CET
You may be interested in
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
When to consider device therapy in HFrEF
thumbnail
Congress Session
Navigating through heart failure device therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources